Readystate Asset Management »

Revance Therapeutics shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.0M 5.0M 0.81
2023-06-30 $16M 15M 1.06
2023-03-31 $22M 18M 1.23

More positions owned by Readystate Asset Management

Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Rivian Automotive Note 3.625%10/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Cyberark Software SHS (CYBR)
EXACT Sciences Corporation (EXAS)
Bentley Sys Note 0.375% 7/0 (Principal)
Itron Note 1.375% 7/1 (Principal)
Workiva Com Cl A (WK)
Dayforce Note 0.250% 3/1 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Freshpet Note 3.000% 4/0 (Principal)
Alarm Com Hldgs Note1/1 (Principal)
Wisdomtree Note 3.250% 8/1 (Principal)

View all positions for Readystate Asset Management